Abstract
Purpose. To evaluate if the cross-linking of gelatin affects in vivo capsule disintegration.
Methods. Scintigraphic investigation in nine healthy volunteers to provide for a real time visualisation of capsule disintegration.
Results. The moderately stressed capsules failed the USP dissolution specification for acetaminophen capsule when tested in water and conventional SGF but passed with the addition of pepsin. Moderately stressed capsules started to disintegrate at 10 ± 6 minutes (range 6 to 24 minutes) compared to 8 ± 2 minutes (range 5 to 11 minutes) for the unstressed capsule.
Conclusions. The results of the study clearly demonstrate that with the incisive technique of gamma scintigraphy there are no differences in the in vivodisintegration properties of moderately stressed and unstressed capsules.
Similar content being viewed by others
REFERENCES
G. A. Digenis, T. B. Gold, and V. P. Shah. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J. Pharm. Sci. 83:915–921 (1994).
D. Cadé, N. Madit, and E. T. Cole. Development of a test procedure to consistently cross-link hard gelatin capsules with formal-dehyde. Pharm. Res. 11:5–147 (1994).
M. Dey, R. Enever, M. Kraml, D. G. Prue, D. Smith, and R. Weierstall. The Dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperatures. Pharm. Res. 10:1295–1300 (1993).
H. Malinowski. Overview of the process: Issues, Research and Outcome. AAPS: “Hard and Soft Gelatin Capsules: Issues, Research and Outcome” Boston (1997).
E. T. Colé, N. Madit, and D. Cadé. Method of stressing hard gelatin capsules. AAPS: “Hard and soft gelatin capsules: Issues, Research and Outcome” Boston (1997).
R. M. Mhatre, H. Malinowski, H. Nguyen, M. C. Meyer, A. B. Straughn, L. Lekso, and R. L. Williams. The effects of cross linking in gelatin capsules on the bioequivalence of acetaminophen. Pharm Res. 14(11):S–251 (1997).
V. A. Gray. Two-tier dissolution testing. AAPS: “Hard and soft gelatin capsules: issues, research and outcome” Boston (1997).
I. R. Wilding, A. J. Coupe, and S. S. Davis. The role of gamma scintigraphy in oral drug delivery. Adv. Drug Del. Rev. 7:87–117 (1991).
S. P. Newman and I. R. Wilding. The importance of gamma scintigraphy in pharmaceutical development. J. Pharm. Med. 6:21–33 (1996).
J. A. Ganley, J. McEwan, R. T. Calvert, and M. C. J. Barker. The effect of in vivo dispersion and gastric emptying on glibenclamide absorption from a novel, rapidly dissolving capsule formulation. J. Pharm. Pharmacol. 36:734–739 (1984).
D. Y. Graham, J. L. Smith, and A. A Bouvet. What happens to tablets and capsules in the stomach: Endoscopic comparison of disintegration and dispersion characteristics of two microencapsulated potassium formulations. J. Pharm. Sci. 79:420–424 (1990).
C. J. Kenyon, F. Stewart, G. McClelland, and I. R. Wilding. The use of pharmacoscintigraphy to elucidate food effects observed with a novel proteinase inhibitor (Saquinavir). Pharm. Res. 15:415–420 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brown, J., Madit, N., Cole, E.T. et al. The Effect of Cross-Linking on the In Vivo Disintegration of Hard Gelatin Capsules. Pharm Res 15, 1026–1030 (1998). https://doi.org/10.1023/A:1011973909815
Issue Date:
DOI: https://doi.org/10.1023/A:1011973909815